News
Biomarkers may indicate severity of COVID in children
October 15, 2021
"A model of six miRNAs was able to discriminate between severe and nonsevere infections with high sensitivity and accuracy in a preliminary analysis."
News
No short-term death risk in elderly after COVID-19 vaccines
October 13, 2021
Early reports of deaths shortly after mRNA-based vaccination of very frail elderly patients in Norway prompted a nationwide safety study.
News
Omega-3s tame inflammation in elderly COVID-19 patients
October 13, 2021
Those who received an intravenous infusion had significant decreases from baseline to end of treatment in the neutrophil-to-lymphocyte ratio.
News
Case reports underscore risk of cerebral edema, AFCE in children with COVID-19
October 7, 2021
Neurologists urge colleagues to watch for similar cases in children.
News
Antibody cocktail reduces chance of developing COVID
October 4, 2021
“This is the first long-acting combination of monoclonal antibodies that represents a potential new option to augment COVID-19 prevention.”
News
Age, C-reactive protein predict COVID-19 death in diabetes
September 29, 2021
“This means we can easily identify patients early on in their hospital stay who will likely require more aggressive interventions to try and improve survival.”
News
Remdesivir sharply cuts COVID hospitalization risk, Gilead says
September 23, 2021
An RCT evaluated the efficacy and safety of a 3-day course of intravenous remdesivir in an analysis of 562 nonhospitalized patients at high risk for disease progression.
![1]()
News
EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinition
September 20, 2021
Cardiologists have long defined heart failure as involving reduced or preserved ejection fraction. Results from big empagliflozin trials say forget that.
News
Poor lung function linked to risk for sudden cardiac death
September 16, 2021
Every standard deviation decrease in forced expiratory volume in 1 second (FEV1) was associated with a 23% increase in risk for sudden cardiac death.
![1]()
News
PRESERVED-HF: Dapagliflozin improves physical limitations in patients with HFpEF
September 14, 2021
The SGLT2 inhibitor dapagliflozin boosted KCCQ scores and 6-minute walk distance in HFpEF patients in a 324-patient randomized trial.
